ProQR Therapeutics N.V. (NASDAQ: PRQR)
$3.6100
-0.0100 ( -0.28% ) 0.0K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Market Data
Open
$3.6100
Previous close
$3.6200
Volume
0.0K
Market cap
$295.62M
Day range
$3.6200 - $3.6200
52 week range
$1.1800 - $4.6200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 70 | Nov 07, 2024 |
| 6-k | Form 6-K | 6 | Oct 25, 2024 |
| 6-k | Form 6-K | 70 | Aug 08, 2024 |
| 6-k | Form 6-K | 1 | May 22, 2024 |
| 6-k | Form 6-K | 72 | May 09, 2024 |
| 6-k | Form 6-K | 2 | May 08, 2024 |
| 6-k | Form 6-K | 9 | Apr 23, 2024 |
| 6-k | Form 6-K | 2 | Apr 19, 2024 |
| 6-k | Form 6-K | 2 | Mar 13, 2024 |
| 20-f | Annual reports | 122 | Mar 13, 2024 |